LLY

1,094.64

-3.09%↓

JNJ

227.39

-1.66%↓

ABBV

217.23

-0.49%↓

UNH

377.5

-2.18%↓

MRK

118.74

-1.48%↓

LLY

1,094.64

-3.09%↓

JNJ

227.39

-1.66%↓

ABBV

217.23

-0.49%↓

UNH

377.5

-2.18%↓

MRK

118.74

-1.48%↓

LLY

1,094.64

-3.09%↓

JNJ

227.39

-1.66%↓

ABBV

217.23

-0.49%↓

UNH

377.5

-2.18%↓

MRK

118.74

-1.48%↓

LLY

1,094.64

-3.09%↓

JNJ

227.39

-1.66%↓

ABBV

217.23

-0.49%↓

UNH

377.5

-2.18%↓

MRK

118.74

-1.48%↓

LLY

1,094.64

-3.09%↓

JNJ

227.39

-1.66%↓

ABBV

217.23

-0.49%↓

UNH

377.5

-2.18%↓

MRK

118.74

-1.48%↓

Home・Aktien・Schrodinger Inc

Schrodinger Inc

Open

BrancheGesundheitswesen

15.26 11.14

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

13.75

Max

15.39

Schlüsselkennzahlen
By Trading Economics
Einkommen	-196M -60M
Verkäufe	-29M 59M
EPS	-0.62
Gewinnspanne	-102.456
Angestellte	850
EBITDA	-85M -49M

Empfehlungen
By TipRanks
Empfehlungen	Buy
12-Monats-Prognose	+41.99% upside

Dividenden
By Dow Jones
Nächstes Ergebnis	5. Aug. 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	30M 994M
Vorheriger Eröffnungskurs	4.12
Vorheriger Schlusskurs	15.26

Nachrichtenstimmung

By Acuity

20%

80%

31 / 344 Ranking in Healthcare

Schrodinger Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

28. Mai 2026, 22:47 UTC

Ergebnisse

Costco 3Q Sales Rise as Value Offerings Draw Pressured Consumers -- Update

28. Mai 2026, 20:45 UTC

Ergebnisse

Costco 3Q Profit Rises as Value Offerings Draw Pressured Consumers

28. Mai 2026, 23:43 UTC

Market Talk

Nikkei May Rise on Hopes for U.S.-Iran Peace Deal -- Market Talk

28. Mai 2026, 23:39 UTC

Market Talk

Gold Edges Lower as Traders Assess Potential U.S.-Iran Deal -- Market Talk

28. Mai 2026, 23:31 UTC

Market Talk

KMD Could Realize Value From Selling Either Oboz or Rip Curl -- Market Talk

28. Mai 2026, 23:17 UTC

Market Talk

Mainfreight Steering Its Way Out of Tough Period -- Market Talk

28. Mai 2026, 23:02 UTC

Market Talk

Costco Has Started Submitting Tariff Refund Claims -- Market Talk

28. Mai 2026, 22:41 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

28. Mai 2026, 22:41 UTC

Market Talk

MongoDB Still Getting More Growth From Established Customers Than AI -- Market Talk

28. Mai 2026, 22:37 UTC

Market Talk

Akquisitionen, Fusionen, Übernahmen

M&A-Related Insurance Payments In North America Rise -- Market Talk

28. Mai 2026, 22:04 UTC

Akquisitionen, Fusionen, Übernahmen

CN: Surface Transportation Board Was Right to Freeze the UP-NS Merger and Demand More Info

28. Mai 2026, 22:04 UTC

Akquisitionen, Fusionen, Übernahmen

CN: This Confirms What CN and Many Stakeholders Have Said All Along, UP and NS Still Have Not Submitted a Credible Case to Support Their Proposed Merger >CNI

28. Mai 2026, 21:12 UTC

Ergebnisse

Akquisitionen, Fusionen, Übernahmen

Synopsys Was the Worst S&P 500 Stock Thursday Despite Earnings Beat With AI and Merger in Focus -- Barrons.com

28. Mai 2026, 21:00 UTC

Ergebnisse

Dell Stock Soars on Blowout Earnings. The Outlook Bests Analysts by $20 Billion. -- Barrons.com

28. Mai 2026, 20:57 UTC

Ergebnisse

Dell Stock Soars on Blowout Earnings -- Barrons.com

28. Mai 2026, 20:55 UTC

Ergebnisse

Costco Wholesale Sees a Mixed Quarter, Misses Earnings Estimates -- Barrons.com

28. Mai 2026, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

28. Mai 2026, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

28. Mai 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

28. Mai 2026, 20:48 UTC

Heiße Aktien

Stocks to Watch Recap: Snowflake, Union Pacific, Hormel Foods -- WSJ

28. Mai 2026, 20:34 UTC

Ergebnisse

One of the S&P 500's Highest Dividends Looks Even Better Now -- Barrons.com

28. Mai 2026, 20:31 UTC

Ergebnisse

Li and XPeng Both Miss Earnings Estimates. One Chinese EV Maker's Stock Is Rising. -- Barrons.com

28. Mai 2026, 20:28 UTC

Ergebnisse

Best Buy's 5% Dividend Yield Looks Even Better After Earnings -- Barrons.com

28. Mai 2026, 20:26 UTC

Ergebnisse

Dell Stock Soars on Blowout Earnings -- Barrons.com

28. Mai 2026, 20:20 UTC

Ergebnisse

Costco 3Q Membership Fees $1.37B

28. Mai 2026, 20:20 UTC

Ergebnisse

Costco 3Q Net Sales $69.15B

28. Mai 2026, 20:19 UTC

Ergebnisse

Costco 3Q Adj Same-Store Sales, Which Excludes Impacts From Gas Prices and Foreign Exchange, Rose 6.6% >COST

28. Mai 2026, 20:19 UTC

Ergebnisse

Costco 3Q Adjusted Digitally-Enabled Sales Rose 20.8% >COST

28. Mai 2026, 20:17 UTC

Ergebnisse

Costco 3Q Digitally-Enabled Sales Rose 21.5% >COST

28. Mai 2026, 20:17 UTC

Ergebnisse

Costco 3Q Same-Store Sales Up 9.8% >COST

Peer-Vergleich

Kursveränderung

Schrodinger Inc Prognose

Kursziel

By TipRanks

41.99% Vorteil

12-Monats-Prognose

Durchschnitt 18.8 USD 41.99%

Hoch 24 USD

Tief 13 USD

Basierend auf 7 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Schrodinger Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

7 ratings

Buy

Halten

Sell

Basierend auf 7 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Schrodinger Inc – Dist abgegeben haben.

Stimmung

By Acuity

31 / 344 Ranking in Gesundheitswesen

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Schrodinger Inc

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. It has a research collaboration and license agreement with Novartis AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.